ArticlePharmaceutical statistics
Informing the Borrowing Process for Dose-Finding Trials by Estimating the Similarity Between Population-Specific Dose-Toxicity Curves.
Article in Pharmaceutical statistics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The conduct of dose-finding trials can be specifically challenging in small populations, for example, in pediatric settings. Recently, research has shown that Bayesian borrowing from adult trials combined with appropriately robust prior distributions enables the conduct of pediatric dose-finding trials with very small sample sizes. However, the appropriate degree of borrowing remains a subjective choice, relying on default methods or expert opinion. This paper proposes an approach to empirically determine the degree of borrowing based on a meta-analysis of the similarity between population-specific dose-toxicity curves of other biologically similar compounds. Focusing on the pediatric use case, the approach may be applicable to any dose-finding trial with information borrowing from another population. With the ExNex and a hierarchical model, two popular statistical modeling approaches are applied. The estimated degree of similarity is then translated into the statistical model for the dose-finding algorithm using either variance inflation or robust mixture prior distributions. The performance of each combination of statistical model approaches is investigated in a simulation study. The results with mixture priors are promising for the application of the proposed methods, especially with many (20) compounds, while variance inflation models require additional fine-tuning and seem to be less robust. With fewer (3 or 7) compounds, our proposed methods are either in line with robust priors that ignore the data from other compounds or are slightly better. We further provide a case study analyzing real dose-finding data from 6 compounds with our models, demonstrating applicability in real-world situations. For clinical trials teams, the decision for or against the proposed approach might be connected to the efforts in terms of time and cost to receive the external data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.